.Ascendis Pharma has become a possible hazard to BioMarin's Voxzogo, reporting period 3 growth disor...
.Though Alkeus Pharmaceuticals' oral eye ailment property neglected to dramatically reduce geographi...
.Along with a trio of biotechs attacking the Nasdaq on Friday, it was very easy to skip a smaller-sc...
.Invulnerable checkpoint preventions are the superheroes of cancer treatment. Medications like Brist...
.Accept to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings a...
.Regeneron is actually back along with long-lasting consequence for its own LAG-3 inhibitor and PD-1...
.AstraZeneca has discussed an early check out the functionality of its in-house antibody-drug conjug...
.After announcing a phase 3 launch based upon good midstage results, iTeos and GSK are eventually di...
.The FDA should be actually even more available as well as collective to let loose a surge in approv...
.It's an extraordinarily active Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara...